Mira Pharmaceuticals Relocates Principal Executive Offices
Ticker: MIRA · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, address-change
TL;DR
Mira Pharma moving HQ to Miami. New address: 1200 Brickell Ave.
AI Summary
On March 13, 2025, Mira Pharmaceuticals, Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131. The company's former name was Mira1a Therapeutics, Inc., with a name change occurring on January 12, 2022.
Why It Matters
This filing signals a change in the company's operational base, which could impact its strategic location and accessibility for stakeholders.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a change in business address and does not involve financial performance or significant operational changes.
Key Players & Entities
- Mira Pharmaceuticals, Inc. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former company name
- March 13, 2025 (date) — Date of report
- January 12, 2022 (date) — Date of name change
- 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131 (location) — New principal executive offices
FAQ
What is the new principal executive office address for Mira Pharmaceuticals, Inc.?
The new principal executive office address is 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
When was the earliest event reported in this Form 8-K?
The earliest event reported was on March 13, 2025.
What was Mira Pharmaceuticals, Inc.'s former name?
Mira Pharmaceuticals, Inc.'s former name was Mira1a Therapeutics, Inc.
On what date did the company change its name from Mira1a Therapeutics, Inc.?
The company changed its name on January 12, 2022.
In which state is Mira Pharmaceuticals, Inc. incorporated?
Mira Pharmaceuticals, Inc. is incorporated in Florida.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).